Brief Communications
Nature 436, 642 (4 August 2005) | doi:10.1038/436642a
Tumour biology: Senescence in premalignant tumours
Manuel Collado1, Jesús Gil2, Alejo Efeyan1, Carmen Guerra1, Alberto J. Schuhmacher1, Marta Barradas1, Alberto Benguría3, Angel Zaballos3, Juana M. Flores4, Mariano Barbacid1, David Beach5 & Manuel Serrano1
Oncogene-induced senescence is a cellular response that may be crucial for protection against cancer development1, 2, but its investigation has so far been restricted to cultured cells that have been manipulated to overexpress an oncogene. Here we analyse tumours initiated by an endogenous oncogene, ras, and show that senescent cells exist in premalignant tumours but not in malignant ones. Senescence is therefore a defining feature of premalignant tumours that could prove valuable in the diagnosis and prognosis of cancer.
- Spanish National Cancer Centre (CNIO), Madrid 28029, Spain
- MRC Clinical Sciences Centre, Imperial College, Hammersmith, London W12 0NN, UK
- Spanish National Centre of Biotechnology (CNB-CSIC), Madrid 28049, Spain
- Department of Animal Surgery and Medicine, Complutense University, Madrid 28040, Spain
- Centre for Cutaneous Research, Institute of Cell and Molecular Science, London E1 2AT, UK
Correspondence to: Manuel Serrano1 Email: mserrano@cnio.es
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Senescence comes of ageNature Medicine News and Views (01 Sep 2005)
Barriers to Ras transformationNature Cell Biology News and Views (01 May 2007)
See all 3 matches for News And ViewsRESEARCH
ATM?Chk2?p53 activation prevents tumorigenesis at an expense of organ homeostasis upon Brca1 deficiencyThe EMBO Journal Article (17 May 2006)
See all 28 matches for Research